Cambridge Associates related stories
All articles and analysis
LPs put emphasis on due diligence as they get selectiveInvestors that are still actively investing are spending more time drilling into fund managers.
Roundtable: European mid-market GPs seek out star qualityThe region’s mid-market private equity firms are being even more selective at a time when sector specialisation is key.
Side Letter: PE's reactionary risksCambridge Associates is urging LPs not to put the brakes on during periods of volatility. Plus: dispatches from ALFI's Private Assets Conference in Luxembourg; and why Schroders is bullish on India. Here's today's brief, for our valued subscribers only.
Side Letter: USS offers GP tipsPerformance isn't the be-all and end-all for some LPs. Plus: Maryland State's cashflow is suffering as a result of its exposure to larger funds; and Amundi has tapped an ex-Montana exec for its secondaries push. Here's today's brief, for our valued subscribers only.
Three areas to watch in impact investingThe industry continues to explore ways to address the challenges that impact faces as it grows.
The rise of impact-linked incentivesIncentives tied to impact targets have come a long way in a short space of time, but best practices around these mechanisms are still evolving.
Mega-fundraises obscure growing LP appetite for smaller buyoutsMore capital is going into the hands of the biggest funds, and yet according to research shared with PEI, LPs are turning their attention to the lower end of the market.
Side Letter: PE's $160trn grailPrivate equity's biggest hitters take aim at the $160 trillion retail market, according to panellists at IPEM Paris. Plus: PE and VC deal values hit a four-year low; and Australian private investments are outperforming publicly traded instruments. Here's today's brief, for our valued subscribers only.
Side Letter: Co-investment cost protectionAn explosion of GP-led secondaries is prompting LPs to ensure their no-fee co-investments won't become more expensive down the line. Plus: Why minority recapitalisations are in vogue; and how AI can improve GP operations. Here's today's brief, for our valued subscribers only.
Cambridge Associates' Auerbach: Why smaller companies are in vogue in PEAverage MOIC and annual revenue and EBITDA growth for US small- and mid-cap deals have outperformed those for businesses at the larger end of the spectrum, says Andrea Auerbach at Cambridge Associates